Augmented capacity of the circulating Tfh cells to secrete IL-21 and imbalance of Tfh/Tfr cells might contribute to the breakdown of self-tolerance in RA, and thus serve as a potential target for therapy and a meaningful tool for disease evaluation. The gene discussed is TFRC; the disease is rheumatoid arthritis.